Lymphoma Survivor Shares His Story: Breakthrough CAR-T Trial | Imugene on 7NEWS Australia | Imugene Limited
Lymphoma Survivor Shares His Story: Breakthrough CAR-T Trial | Imugene on 7NEWS Australia | Imugene Limited
9.7K views4 months ago
linkedin.com
Imugene Azer-cel CAR-T Trial Featured on 10 News | Patient Story | Imugene Limited
Imugene Azer-cel CAR-T Trial Featured on 10 News | Patient Story | Imugene Limited
9.9K views1 month ago
linkedin.com
Groundbreaking cancer trial: Imugene’s CF33 advances in clinical success
Groundbreaking cancer trial: Imugene’s CF33 advances in clinical success
Nov 13, 2024
proactiveinvestors.com.au
Imugene expands CAR T-Cell and Oncolytic Virotherapy trials in Australia and the US
Imugene expands CAR T-Cell and Oncolytic Virotherapy trials in Australia and the US
Nov 10, 2024
proactiveinvestors.com.au
Imugene prepares pivotal azer-cel trial with FDA
Imugene prepares pivotal azer-cel trial with FDA
6 months ago
proactiveinvestors.com.au
Imugene doses first patient in IV arm of Phase 1 onCARlytics trial targeting solid cancers
Imugene doses first patient in IV arm of Phase 1 onCARlytics trial targeting solid cancers
Jun 23, 2024
proactiveinvestors.com
Imugene’s azer-cel shows lasting cancer response
0:46
Imugene’s azer-cel shows lasting cancer response
405 views5 months ago
YouTubeProactive Investors
Imugene’s $20 million boost and cancer trial updates
Feb 2, 2025
proactiveinvestors.com.au
Imugene achieves phase-II clinical trial milestone for HER-Vaxx cancer immunotherapy
Apr 20, 2021
proactiveinvestors.com.au
Imugene highlights azer-cel progress as trial patient enters remission
2 months ago
proactiveinvestors.com.au
Imugene doses first patient in “groundbreaking” Phase 1 OASIS clinical trial
Oct 26, 2023
proactiveinvestors.com
Imugene hits 82% response rate in blood cancer trial - ICYMI
5 months ago
proactiveinvestors.com.au
Imugene CMO and CEO talk trial momentum and immuno-oncology progress
11 months ago
proactiveinvestors.com.au
2:42
Imugene Azer-cel CAR-T Trial Featured on 10 News | Patient Story
2.3K views2 months ago
YouTubeImugene Limited
Imugene advances to combination dosing with Phase 1 onCARlytics solid tumour trial
Mar 11, 2024
proactiveinvestors.com.au
Imugene expands bile tract cancer study as patient shows complete response during MAST trial phase
Apr 15, 2024
proactiveinvestors.com.au
Imugene’s Azer-cel therapy achieves two more complete responses in patients with B-cell lymphoma blood cancer
Feb 13, 2025
proactiveinvestors.com
Imugene's CMO John Byon on latest cancer trial data
11 months ago
proactiveinvestors.com.au
Imugene Phase 1 onCARlytics trial doses first patient in intratumoural combination arm
Nov 11, 2024
proactiveinvestors.com.au
Imugene has cancer vaccine trial data published in prestigious medical journal
Feb 25, 2019
proactiveinvestors.com.au
Leslie Chong, Imugene CEO - Money News
10 months ago
omny.fm
Imugene seeks to activate immune system of cancer patients to identify and eradicate tumours
Jul 31, 2022
proactiveinvestors.co.uk
Leslie Chong on Imugene’s 83% Response Rates Path to FDA Approval | Fear Greed | Imugene Limited
9.9K views1 month ago
linkedin.com
Imugene Investor Webinar - FDA Meeting Results | Imugene Limited
9.7K views4 months ago
linkedin.com
Imugene doses first patient in Phase 2 clinical trial
2 viewsSep 8, 2022
proactiveinvestors.com.au
Imugene’s Phase 1 onCARlytics clinical trial doses first patient in intravenous monotherapy arm
Feb 14, 2024
proactiveinvestors.com
Imugene says Azer-cel could be best-in-class Allogeneic CAR T
Nov 12, 2023
proactiveinvestors.com.au
Imugene secures $2.7m R&D tax refund to support clinical programs
2 months ago
proactiveinvestors.com
Imugene sees positive early signs in VAXINIA trial; “may be potent anti-cancer drug”
Nov 6, 2023
proactiveinvestors.com.au
Imugene well positioned to deliver 2024 milestones
Dec 28, 2023
proactiveinvestors.com
See more